Abstract
Abnormalities of coagulation have been reported in patients with thyroid dysfunction, although there is no clear information to explain the mechanism behind such irregularities. We are presenting a case of subclinical hypothyroidism that came with coagulation disturbance (hypocoagulation). Her symptoms resolved with leothyroxin in 4 weeks. Further studies are needed to clear the pathogenesis of the coagulation disturbance in such setting. The article also outlines some patents on hypothyroidism and hyperthyroidism.
Keywords: Hemostasis, hypercoagulability hypocoagulability, subclinical thyroid dysfunction, thyroid dysfunction, hypothyroidism, Graves’ disease, vitamin-mineral complexes, levothyroxine, Willebrand factor
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Title:Subclinical Hypothyroidism and Homeostatic Disturbances: Case Report and Literature Review
Volume: 6 Issue: 2
Author(s): Parvaneh Ehsanzadeh-Cheemeh, Michelle Thompson and Michal Miller
Affiliation:
Keywords: Hemostasis, hypercoagulability hypocoagulability, subclinical thyroid dysfunction, thyroid dysfunction, hypothyroidism, Graves’ disease, vitamin-mineral complexes, levothyroxine, Willebrand factor
Abstract: Abnormalities of coagulation have been reported in patients with thyroid dysfunction, although there is no clear information to explain the mechanism behind such irregularities. We are presenting a case of subclinical hypothyroidism that came with coagulation disturbance (hypocoagulation). Her symptoms resolved with leothyroxin in 4 weeks. Further studies are needed to clear the pathogenesis of the coagulation disturbance in such setting. The article also outlines some patents on hypothyroidism and hyperthyroidism.
Export Options
About this article
Cite this article as:
Ehsanzadeh-Cheemeh Parvaneh, Thompson Michelle and Miller Michal, Subclinical Hypothyroidism and Homeostatic Disturbances: Case Report and Literature Review, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery 2012; 6 (2) . https://dx.doi.org/10.2174/187221412800604590
DOI https://dx.doi.org/10.2174/187221412800604590 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
Related Articles
-
Clinical Approaches Toward Tumor Angiogenesis: Past, Present and Future
Current Pharmaceutical Design Novel VEGF-independent Strategies Targeting Tumor Vasculature: Clinical Aspects
Current Pharmaceutical Design Diagnostic Usage of Low Dose CT in Solitary Pulmonary Nodule Follow Up in Daily Practice
Current Medical Imaging A Network Pharmacology Approach to Reveal the Underlying Mechanisms of Zuogui Yin in the Treatment of Male Infertility
Combinatorial Chemistry & High Throughput Screening Kinase Regulation by Sulfur and Selenium Containing Compounds
Current Cancer Drug Targets Demystifying the ACE Polymorphism: From Genetics to Biology
Current Pharmaceutical Design Recent Clinical Aspects of Hyperprolactinemia Induced by Antipsychotics
Reviews on Recent Clinical Trials Established and In-trial GPCR Families in Clinical Trials: A Review for Target Selection
Current Drug Targets IL-6, IL-1β, and MDA Correlate with Thrombolysis in Myocardial Infarction (TIMI) Risk Score in Patients with Acute Coronary Syndrome
Recent Advances in Inflammation & Allergy Drug Discovery Non-Hodgkins Lymphoma: Review of Conventional Treatments
Current Pharmaceutical Biotechnology Aurora B: A New Prognostic Marker and Therapeutic Target in Cancer
Current Medicinal Chemistry Development of RNA Aptamer-Based Therapeutic Agents
Current Medicinal Chemistry Patents on Technologies of Human Tissue and Organ Regeneration from Pluripotent Human Embryonic Stem Cells
Recent Patents on Regenerative Medicine Cytokine/Antibody Complexes: An Emerging Class of Immunostimulants
Current Pharmaceutical Design Statins and Alkylphospholipids as New Anticancer Agents Targeting Lipid Metabolism
Anti-Cancer Agents in Medicinal Chemistry Pro-Oncogenic Cell Signaling Machinery as a Target for Oncolytic Viruses
Current Pharmaceutical Biotechnology Complex 3D Models to Study Drug Targeting of Invadopodia
Clinical Cancer Drugs Genetic Alterations in Differentiated Thyroid Cancers
Endocrine, Metabolic & Immune Disorders - Drug Targets Several Classes of Natural Products with Metal ion Chelating Ability
Current Organic Chemistry Zebrafish As a Genetic Model in Pre-Clinical Drug Testing and Screening
Current Medicinal Chemistry